Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment

Clinical trial NCT02128490 · COMPLETED

Trial details

NCT number: NCT02128490
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gout Moderate Renal Impairment

Start date: 2014-05-01
Primary completion: 2015-09-01
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.